Goldman Sachs reinstated Allegiant Travel (ALGT) at Buy, citing merger synergies as the primary investment thesis. The reinstatement puts a floor under a stock trading near multi-year lows with negative EPS, raising the question of whether synergy capture can offset a structurally challenged P&L.
Goldman's reinstatement at Buy — with explicit synergy framing — signals the firm sees a concrete cost/revenue integration path that the market has not yet priced, and the modest +3.7% revenue growth gives the thesis a functioning top line to lever.
With diluted EPS at -$2.48 and net margins negative, ALGT's entire re-rating case rests on unproven synergy execution, and airlines have a long history of integration cost overruns that can extend loss periods well beyond consensus timelines.